Ingrid Choong
Nessuna posizione attualmente
Patrimonio netto: 3 396 $ in data 30/04/2024
Storia della carriera di Ingrid Choong
Precedenti posizioni note di Ingrid Choong
Società | Posizione | Inizio | Fine |
---|---|---|---|
EIGER BIOPHARMACEUTICALS, INC. | Direttore Tecnico/Scientifico/R&S | - | 01/09/2023 |
Contatto Relazioni con gli Investitori | 01/01/2008 | - | |
Public Communications Contact | 01/01/2008 | - | |
Eiger BioPharmaceuticals, Inc. /Old/
Eiger BioPharmaceuticals, Inc. /Old/ Pharmaceuticals: MajorHealth Technology Eiger BioPharmaceuticals, Inc. provides pharmaceutical products. It operates as a biopharmaceutical company, which focuses on the discovery and development of new antiviral agents against novel targets in the treatment of hepatitis. The firm’s pipeline includes clinical stage assets and preclinical new chemical entities (NCEs) shown to possess antiviral activity against Hepatitis C, Hepatitis D, and a wide array of other viruses. It also conducts multiple clinical proofs of concept studies in multiple clinical sites in HCV and HDV patients. The company was founded by Jeffrey S. Glenn in 2008 and is headquartered in Palo Alto, CA. | Contatto Relazioni con gli Investitori | - | 29/03/2016 |
Corporate Officer/Principal | 11/08/2011 | - | |
VIRACTA THERAPEUTICS, INC. | Corporate Officer/Principal | 01/01/1999 | 01/01/2008 |
Formazione di Ingrid Choong
California Institute of Technology | Undergraduate Degree |
University of California, Berkeley | Doctorate Degree |
Statistiche
Distribuzione geografica
Stati Uniti | 6 |
Posizioni
Investor Relations Contact | 2 |
Corporate Officer/Principal | 2 |
Undergraduate Degree | 1 |
Settori
Health Technology | 4 |
Consumer Services | 3 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
Società quotate in Borsa | 1 |
---|---|
EIGER BIOPHARMACEUTICALS, INC. | Health Technology |
Aziende private | 2 |
---|---|
Eiger BioPharmaceuticals, Inc. /Old/
Eiger BioPharmaceuticals, Inc. /Old/ Pharmaceuticals: MajorHealth Technology Eiger BioPharmaceuticals, Inc. provides pharmaceutical products. It operates as a biopharmaceutical company, which focuses on the discovery and development of new antiviral agents against novel targets in the treatment of hepatitis. The firm’s pipeline includes clinical stage assets and preclinical new chemical entities (NCEs) shown to possess antiviral activity against Hepatitis C, Hepatitis D, and a wide array of other viruses. It also conducts multiple clinical proofs of concept studies in multiple clinical sites in HCV and HDV patients. The company was founded by Jeffrey S. Glenn in 2008 and is headquartered in Palo Alto, CA. | Health Technology |
Sunesis Pharmaceuticals, Inc.
Sunesis Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Sunesis Pharmaceuticals, Inc. engages in the development and commercialization of new oncology therapeutics for the treatment of solid and hematologic cancers. The firm's activities include conducting research and development internally and through corporate collaborators, in-licensing and out-licensing pharmaceutical compounds and technology, conducting clinical trials and raising capital. The company was founded on February 10, 1998 and is headquartered in South San Francisco, CA. | Health Technology |
- Borsa valori
- Insiders
- Ingrid Choong
- Esperienza